During this webinar three experts will present key considerations in the design of rigorous preclinical studies in rodent models of muscular dystrophy. The presentation will include topics such as animal model selection, assays and endpoints, and how your results can inform translation to the clinic.
Key topics covered during this webinar include…
- Consideration when designing a pre-clinical efficacy study in rodent models of muscular dystrophy
- Choosing the most appropriate animal models, assays and endpoints
- How your results can inform the translation to the clinic